home / stock / myco:cc / myco:cc news

MYCO:CC News and Press, MYDECINE INNOVATIONS GROUP INC. From 02/05/24

Stock Information
Company Name: MYDECINE INNOVATIONS GROUP INC.
Stock Symbol: MYCO:CC
Market: AQNC
Website: mydecine.com
Menu
MYCO:CC MYCO:CC Quote MYCO:CC Short MYCO:CC News MYCO:CC Articles MYCO:CC Message Board
Get MYCO:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
MYCO:CC - Canadian Companies Moving the Markets, Morning edition
Mon, Feb 05, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada ATHA Energy Corp. (SASK) fell 5.7% to $1.16 on volume of 3,621,558 shares Mydecine Innovations Group Inc. (MYCO) rose 0.0% to $0.015 on volume of 2,597,289 shares Jushi Holdings Inc. - Ordinary Shares - Class B (Sub Voting) (JUSH) rose 7.8% to $...
MYCO:CC - Mydecine Innovations Group Announces Director Resignation

VANCOUVER, British Columbia, Feb. 02, 2024 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE: 0NF0), a forefront biotechnology company dedicated to revolutionizing mental health and addiction treat...

MYCO:CC - Canadian Companies Moving the Markets, Morning edition
Wed, Jan 31, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada NuranWireless (NUR) rose 17.9% to $0.165 on volume of 3,314,384 shares Star Navigation Systems Group Ltd. (SNA) rose 0.0% to $0.02 on volume of 3,211,215 shares Revive Therapeutics Ltd - Ordinary Shares (RVV) fell 14.3% to $0.03 on volume of 2,2...

MYCO:CC - Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound

VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA), a forefront biotechnology company dedicated to revolutionising mental health and addiction treatm...
MYCO:CC - Mydecine Announces Update Regarding the Special Access Program

DENVER, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental ...

MYCO:CC - Canadian Securities Exchange Reports October 2023 Performance Figures

Toronto, Ontario--(Newsfile Corp. - November 17, 2023) - The Canadian Securities Exchange ("CSE" or "the Exchange") today announced market statistics for October 2023. October 2023 Operating Statistics Trading volume of CSE-listed securities totaled 915 million shares; Trading value of CSE-...

MYCO:CC - InvestorNewsBreaks - Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) Files Prospectus Supplement, Closes Share Subscription Agreements

Mydecine Innovations (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, has filed a shelf prospectus supplement to...
MYCO:CC - Mydecine Innovations Group Files Prospectus Supplement, Announces Closing Under Share Subscription Agreements

VANCOUVER, British Columbia, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA) a biotechnology company engineering the next wave of innovative medications and treatment prot...

MYCO:CC - InvestorNewsBreaks - Mydecine Innovations Group Inc. (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) Reports on Company Progress in Q4 2023 Update

Mydecine Innovations (CSE: MYCO) (AQSE: MYIG) (OTC: MYCOF) , a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD, has released a fourth-quarter 2023 company...

MYCO:CC - Mydecine Provides Q4 2023 Business Update

VANCOUVER, British Columbia, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (CSE:MYCO) (AQSE:MYIG) (OTC:MYCOF) (FSE:0NFA), a biotechnology company engineering the next wave of innovative medications and treatment pro...
Previous 10 Next 10